###begin article-title 0
High Levels of MeCP2 Depress MHC Class I Expression in Neuronal Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: EJ JM. Performed the experiments: EM JM LK SP HB. Analyzed the data: EJ JM LK SP. Wrote the paper: EJ JM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The expression of MHC class I genes is repressed in mature neurons. The molecular basis of this regulation is poorly understood, but the genes are particularly rich in CpG islands. MeCP2 is a transcriptional repressor that binds to methylated CpG dinucleotides; mutations in this protein also cause the neurodevelopmental disease called Rett syndrome. Because MHC class I molecules play a role in neuronal connectivity, we hypothesised that MeCP2 might repress MHC class I expression in the CNS and that this might play a role in the pathology of Rett syndrome.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 562 571 562 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird</sup>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
We show here that transiently transfected cells expressing high levels of MeCP2 specifically downregulate cell-surface expression of MHC class I molecules in the neuronal cell line N2A and they prevent the induction of MHC class I expression in response to interferon in these cells, supporting our first hypothesis. Surprisingly, however, overexpression of the mutated forms of MeCP2 that cause Rett syndrome had a similar effect on MHC class I expression as the wild-type protein. Immunohistological analyses of brain slices from MECP2 knockout mice (the MeCP2tm1.1Bird strain) demonstrated a small but reproducible increase in MHC class I when compared to their wild type littermates, but we found no difference in MHC class I expression in primary cultures of mixed glial cells (mainly neurons and astrocytes) from the knockout and wild-type mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
These data suggest that high levels of MeCP2, such as those found in mature neurons, may contribute to the repression of MHC expression, but we find no evidence that MeCP2 regulation of MHC class I is important for the pathogenesis of Rett syndrome.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 63 66 63 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Amir1">[1]</xref>
###xml 67 70 67 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Bienvenu1">[3]</xref>
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Percy1">[4]</xref>
###xml 434 437 434 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Hagberg1">[5]</xref>
###xml 438 441 438 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Zoghbi1">[7]</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Quaderi1">[8]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-DEsposito1">[9]</xref>
###xml 165 170 <span type="species:ncbi:9606">Girls</span>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
Mutations in the X-linked gene MECP2 cause Rett syndrome (RTT) [1]-[3], a progressive neurodevelopmental disorder that affects around 1 in 10,000 female births [4]. Girls with RTT develop normally until 6-18 months old, when they begin to regress, losing the speech and hand skills they had acquired. Most patients develop severe mental retardation, seizures, repetitive hand movements, irregular breathing and motor-control problems [5]-[7]. MECP2 encodes the methyl-CpG-binding protein 2 (MeCP2) [8], [9], which is thought to regulate gene expression, but we do not yet understand how mutations in this protein produce the pathological features of RTT.
###end p 9
###begin p 10
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 20 24 20 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Chen1">[10]</xref>
###xml 25 29 25 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Pelka1">[12]</xref>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Shahbazian1">[13]</xref>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Chen1">[10]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Gemelli1">[14]</xref>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Luikenhuis1">[15]</xref>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Giacometti1">[16]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Guy2">[17]</xref>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
MECP2 knockout mice [10]-[12] and mice expressing a truncated form of MeCP2 [13] display a RTT-like phenotype, demonstrating that MeCP2 deficiency is sufficient to induce the syndrome. Moreover, mice in which MECP2 was conditionally deleted in neurons had a similar phenotype to RTT patients [10], [14], and MeCP2-deficient mice were cured by expression of a transgenic MECP2 gene specifically in post-mitotic neurons [15]. These findings indicate that the pathology of RTT is due to the lack of MeCP2 in the mature central nervous system (CNS). Two recent studies have shown that the neurological defects in mutant mice are reversed by restoration of MeCP2 expression in neurons, even at late postnatal stages [16], [17], suggesting that gene therapy may be feasible.
###end p 10
###begin p 11
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kriaucionis1">[18]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Mnatzakanian1">[19]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan1">[20]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan2">[21]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan3">[22]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Klose1">[23]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan4">[24]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kokura1">[27]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Jeffery1">[28]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Young1">[29]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Georgel1">[30]</xref>
###xml 860 864 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Horike1">[31]</xref>
###xml 1046 1050 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kimura1">[32]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Fuks1">[33]</xref>
The MECP2 mRNA is alternatively spliced to generate two protein isoforms (MeCP2A and MeCP2B) that differ at their N-termini. Both forms are expressed ubiquitously, but MeCP2B is more abundant than MeCP2A in the CNS [18], [19]. MeCP2 represses transcription [20] by binding through its methyl-CpG-binding domain (MBD) [21] to methylated CpG nucleotides [22], [23] and recruiting co-repressors that bind to its transcription repression domain (TRD) [24]-[27]. Other studies, however, indicate that MeCP2 is a multifunctional protein that affects gene regulation at many levels: MeCP2 interacts with an RNA-binding protein called Y box-binding protein 1 to regulate splicing of target RNAs [28], [29]; two studies suggest that MeCP2 influences gene expression by participating in chromatin architecture, independently of its capacity to bind methylated DNA [30], [31]; moreover, MeCP2 associates with the DNA methyltransferase Dnmt1 bound to hemi-methylated DNA and may thus participate in maintaining the methylation state of newly synthesised DNA [32], [33].
###end p 11
###begin p 12
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Chen2">[34]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Chang1">[36]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Peddada1">[37]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nuber1">[38]</xref>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
Our knowledge of the activities of MeCP2 suggests that the pathologies associated with MECP2 mutations are most likely due to the misregulation of neuronal genes. Several studies have identified possible target genes that are controlled by MeCP2, including the gene encoding brain-derived neurotrophic factor (BDNF) [34]-[36], genes encoding inhibitors of differentiation [37], and genes regulated by glucocorticoids [38]; their expression is altered in MECP2 knockout mice, but whether this is responsible for the neuropathology seen in RTT remains questionable.
###end p 12
###begin p 13
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Tykocinski1">[39]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Corriveau1">[40]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Huh1">[41]</xref>
We hypothesised that genes encoding MHC class I molecules (MHC class I) might be amongst those that MeCP2 regulates in the CNS because these genes have a particularly high CG content [39]. Two studies have demonstrated that expression of MHC class I is dynamically regulated during the post-natal development of the CNS and that MHC class I expression is necessary for the activity-dependent synaptic rearrangements that occur during normal brain development and for normal synaptic plasticity in the mature hippocampus [40], [41]. If MHC class I expression was regulated by MeCP2, defects in these developmental functions of MHC class I might contribute to the symptoms of RTT.
###end p 13
###begin p 14
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Neumann1">[42]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Huh1">[41]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Syken1">[43]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-LeindersZufall1">[46]</xref>
MHC class I is generally not expressed in adult brain except in response to cytokines (i.e. inflammation) or injury [42]. This is believed to protect nervous tissue, which regenerates poorly, from cytotoxic attack by the immune system. Several lines of evidence, however, suggest that MHC class I is expressed in specific areas of the mature brain, as well as during brain development, and they evoke a function for MHC class I molecules in neuronal signalling [41], [43]-[46]. This suggests that, rather than being simply shut down, MHC class I genes must be very finely regulated throughout the CNS by activators and inhibitors that, on the one hand, allow their function during development and, on the other hand, ensure their silencing in the majority of neurons in which their expression could be detrimental.
###end p 14
###begin p 15
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 215 220 <span type="species:ncbi:9606">child</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
We reasoned that misregulated expression of MHC class I in the brain due to mutations in MeCP2 might disturb the establishment and maintenance of neuronal connections and remodelling in the hippocampus during early child development and thus account for the neurodevelopmental disorders of RTT. We therefore investigated whether MHC class I gene expression is under the control of MeCP2 in neuronal cell lines in culture and whether MHC class I gene expression is affected in MECP2 knockout mice.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Overexpression of MeCP2 downregulates basal MHC class I
###end title 17
###begin p 18
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 373 378 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-</italic>
###xml 554 562 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1</xref>
###xml 832 841 829 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1A</xref>
###xml 1184 1185 1181 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 1188 1189 1185 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1192 1193 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1200 1204 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1909 1913 1903 1904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1931 1940 1922 1931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1B</xref>
###xml 82 88 <span type="species:ncbi:10090">murine</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 172 178 <span type="species:ncbi:10090">murine</span>
###xml 628 634 <span type="species:ncbi:9986">rabbit</span>
To investigate whether MeCP2 represses MHC class I expression, we transfected the murine neuronal cell line N2A with pCMX plasmids that transiently express either human or murine MeCP2A. Forty-eight hours after transfection, we evaluated by flow cytometry the cell surface levels of Kk, Ld and Dd (the three 'classical' MHC class I molecule heavy chains expressed by N2A), beta-2-microglobulin (the light chain subunit of MHC class I) and, as control, the transferrin receptor, a cell surface glycoprotein of similar size and half-life to MHC molecules (Figure 1). The expression of MeCP2 in transfected cells was detected by a rabbit anti-MeCP2 polyclonal antibody on cells fixed and permeabilised after they had been stained for MHC class I cell surface expression. Dot plot representative examples of these analyses are shown on Figure 1A, where each dot represents an individual cell, and an decrease in MHC staining results in a shift to the left, and an increase in MeCP2 in an upward shift. Because these are transient transfections, MeCP2 overexpression is detected in only a certain percentage (typically 20-30%) of the cells. As can be seen for all MHC class I molecules ( Kk, Ld, Dd ) and beta-2-microglobulin, in the cloud of cells overexpressing MeCP2, we detected a clear shift to the left compared to the lower cloud of untransfected cells and to mock-transfected cells, indicating a reduction of the cell surface expression of all these molecules in the cells that overexpress MeCP2. This effect appears to be specific for these molecules since the level of transferrin receptor was basically unaffected by MeCP2 overexpression. The reproducibility and statistical significance of these observations was ascertained by repeating this experiment many times, which also allowed us to conclude that MeCP2 overexpression results in a similar 40% decrease of all three MHC class I molecules and of beta-2-microglobulin (Figure 1B). In the experiment shown, the mock-transfected cells were simply treated with the transfection reagent, but similar results were obtained when the negative control consisted of empty plasmids, or plasmids expressing other proteins such as GFP (not shown).
###end p 18
###begin title 19
MeCP2 overexpression diminishes MHC class I expression.
###end title 19
###begin p 20
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 870 871 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 952 953 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1087 1088 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1092 1093 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1993 1994 1986 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2007 2008 2000 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 58 64 <span type="species:ncbi:10090">murine</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 508 513 <span type="species:ncbi:9606">human</span>
###xml 859 864 <span type="species:ncbi:10090">mouse</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
###xml 1076 1081 <span type="species:ncbi:9606">human</span>
###xml 1714 1717 <span type="species:ncbi:10116">rat</span>
###xml 1723 1728 <span type="species:ncbi:10090">mouse</span>
N2A cells transfected with pCMX vectors expressing either murine or human MeCP2 were immunostained for one of the three MHC class I molecules (Kk, Ld or Dd), beta2-microglobulin or the transferrin receptor on the cell surface as well as for intracellular MeCP2. The level of staining was then analysed by fluorescence-activated cell sorting. Panel A: Dot plots of the amount of surface antigen (x-axis) against the amount of intracellular MeCP2 (y-axis) in cells transiently transfected with pCMX expressing human MeCP2 and analysed 48 hrs later. Panel B: For each kind of staining, the variation in expression level was calculated as the ratio of MFI of MeCP2 overexpressing cells over MFI of mock-transfected cells. The histograms summarise the mean (+/-SEM) of the variation in cell surface levels from 15 independent transfections with vectors expressing mouse MeCP2A (grey fill) and 12 independent transfections with vectors expressing human MeCP2A (black fill). Panel C: N2A and NIH3T3 cells were transfected with empty pcDNA3.1(+) (mock cells) or expressing Myc-tagged human MeCP2A or B isoforms. 48 h after transfection, cells were subjected to double staining against cell surface MHC class I molecules and intracellular Myc-tagged MeCP2, then analyzed by flow cytometry. The variation in expression level of MHC class I molecules was calculated as the ratio of MFI of MeCP2 over-expressing cells over the MFI of mock cells. The histograms represent the mean (+/-SEM) of the cell surface level variation from 4 independent transfections with each of the vectors. Panel D: A representative example of dot-plots obtained for double immunostaining of transiently transfected N2A cells with anti-Myc 9E10 and rat-anti-mouse-MHC I M1/42 monoclonal antibodies. Dotted and continuous circles indicate the different populations expressing high and intermediate levels of MeCP2, respectively. Statistical significance of difference between groups was analysed by using an unpaired t-test (**, p<0.01 ; ***, p<0.001).
###end p 20
###begin p 21
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 932 941 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1C</xref>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1062 1063 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1099 1100 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1109 1110 1109 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 661 664 <span type="species:ncbi:10116">rat</span>
No functional difference has been described between the two isoforms of MeCP2, MeCP2A and MeCP2B. We therefore explored whether these two isoforms had the same effect on MHC class I molecules and whether their effects might differ according to the cell type in which they are expressed. We transfected vectors encoding the Myc-tagged version of human MeCP2A or MeCP2B into either N2A or the mouse fibroblast cell line NIH 3T3. In this experiment, we detected MeCP2 expression by using an anti-Myc9E10 monoclonal antibody because it produced a much stronger signal than the anti-MeCP2 antibody. The level of MHC class I was evaluated at the same time by using a rat anti-pan-MHC antibody, M1/42. The double staining in mock-transfected and transfected cells was analysed by flow cytometry. MeCP2 overexpression induced a similar extent of repression of MHC class I irrespective of the isoform or cell type in which it was expressed (Figure 1C): the cell surface level of MHC class I decreased by approximately 35% when compared to the basal level (p<0.01 in N2A; p<0.001 in NIH 3T3) when either MeCP2A or MeCP2B were overexpressed in N2A or in NIH 3T3 cells.
###end p 21
###begin p 22
###xml 110 114 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 247 256 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1D</xref>
###xml 675 676 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 685 686 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 814 823 811 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1D</xref>
We noted a correlation in these experiments between the repressive effect exerted by MeCP2 on MHC class I and beta-2-microglobulin and the quantity of MeCP2 expressed by the transfected cells: cells expressing high levels of MeCP2 (dotted circle, Figure 1D) had less MHC class I on their surface than cells expressing MeCP2 at lower levels (continuous circle), which expressed levels of MHC class I similar to those in cells in which no MeCP2 staining was detected and to those in mock-transfected cells. Repression of MHC class I expression by MeCP2 therefore appears to require very high levels of MeCP2. We generated stably transfected lines of N2A expressing either MeCP2A or MeCP2B but the levels of protein expressed by these cells was relatively low (at best comparable to those in the continuous circle in Figure 1D). It is therefore of little surprise that the levels of MHC class I expressed by those cells was not discernibly different from that of untransfected cells (not shown). Evaluation by quantitative western blot of the levels of MeCP2 protein expressed in these various transfected cells revealed bands of comparable intensities in stable transfectants and in brain extracts, and bands that were two to five fold more intense in transiently transfected populations (not shown). Since mature neurons represent approximately 15% of all cells in the brain parenchyma, we can further estimate that our stable transfectants express levels of MeCP2 which are roughly one sixth of those found in mature neurons. Conversely, since the efficiency of the transient transfections in this experiment was approximately 10%, we estimate that the levels of MeCP2 attained in high expressors after transient transfections are 20 to 50 fold higher than the levels in stable transfectants (and therefore three to eight fold higher than in intra-cerebral neurons).
###end p 22
###begin title 23
Overexpression of MeCP2 markedly reduces MHC class I upregulation by IFN-gamma
###end title 23
###begin p 24
###xml 260 264 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Gobin1">[47]</xref>
###xml 336 344 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g001">Figure 1</xref>
###xml 569 570 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 755 759 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 892 900 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g002">Figure 2</xref>
###xml 1072 1076 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1158 1167 1136 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g002">Figure 2A</xref>
###xml 1258 1259 1236 1237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1264 1268 1242 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1388 1397 1359 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g002">Figure 2A</xref>
###xml 539 545 <span type="species:ncbi:10090">murine</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
The cytokine IFN-gamma transactivates MHC class I expression predominantly by binding to IFN regulatory factor-1, which binds, in turn, to the interferon-stimulated response element, ISRE, a GC-rich region and therefore a potential binding site also for MeCP2 [47]. Since MeCP2 appeared to act as a repressor of MHC class I expression (Figure 1), we wanted to test whether it would interfere with transactivation of MHC class I expression by IFN-gamma. To do so, we transfected N2A cells with pCMX vectors driving the expression of either murine or human forms of MeCP2A. The following day, these transiently transfected cells were divided into two flasks that were either treated or not with IFN-gamma for 48 hrs. The levels of cell-surface MHC class I, beta-2-microglobulin and transferrin receptor, and intracellular MeCP2, were evaluated by flow cytometry as in the previous experiments (Figure 2). As can be seen by the shift of the clouds between the higher and the lower panels, treatment with IFN-gamma resulted in a two- to four-fold induction of MHC class I and beta2-microglobulin in both mock-transfected populations and transfected populations (Figure 2A). Individual transfected cells expressing MeCP2 at high levels, however, had little more Ld and beta2-microglobulin when treated with IFN-gamma than untreated MeCP2-expressing cells (compare the populations encircled in Figure 2A IFN-gamma with those without IFN-gamma). Cells overexpressing MeCP2 therefore appear to respond to IFN-gamma by upregulating MHC class I to a much lesser extent than do cells not expressing MeCP2.
###end p 24
###begin title 25
Transient overexpression of MeCP2 inhibits MHC class I induction by IFN-gamma.
###end title 25
###begin p 26
###xml 375 376 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 856 857 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 868 869 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 881 882 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 51 57 <span type="species:ncbi:10090">murine</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
N2A cells transfected with pCMX vectors expressing murine or human MeCP2 were treated or not with IFN-gamma for 48 hrs and then double immunostained for cell surface beta2-microglobulin, transferrin receptor or MHC class I and intracellular MeCP2. Panel A: Dot-plots of transfected cells analysed by flow cytometry showing the cell surface level of the MHC class I molecule Ld or beta2-microglobulin (x-axis) plotted against the level of intracellular MeCP2 (y-axis). Panel B: The induction factor was calculated as the ratio of MFI of treated cells (over-expressing MeCP2 or untransfected cells) on MFI of untreated N2A cells. Values used for the histogram are the mean (+/-SEM) of induction factors obtained in seven independent transfection experiments. Statistical significance of difference between groups was analysed by using an unpaired t-test (*, p<0.05; **, p<0.01; ***, p<0.001).
###end p 26
###begin p 27
###xml 156 157 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 160 161 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 164 165 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 176 180 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 229 238 222 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g002">Figure 2B</xref>
###xml 399 404 <span type="species:ncbi:9606">human</span>
The statistical significance of the differences in response to IFN-gamma was confirmed for all three MHC class I molecules expressed by the N2A cell line (Kk, Ld, Dd ) and for beta-2-microglobulin in six independent experiments (Figure 2B), whereas the levels of transferrin receptor were not significantly affected. This effect was also observed in other cell lines such as NIH 3T3 fibroblasts and human HEK 293 cells (not shown).
###end p 27
###begin title 28
MeCP2 mutants retain their repressive effect on MHC class I expression
###end title 28
###begin p 29
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Shahbazian2">[48]</xref>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 521 530 521 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g003">Figure 3A</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Shahbazian1">[13]</xref>
###xml 1006 1015 1006 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g003">Figure 3B</xref>
###xml 1177 1181 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan3">[22]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Lewis1">[49]</xref>
###xml 1222 1223 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1259 1260 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1681 1682 1681 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1785 1794 1785 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g003">Figure 3C</xref>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 1425 1428 <span type="species:ncbi:10116">rat</span>
Many disease-causing mutations of MECP2 have been described [48]. Among them, some occur more frequently than others, and/or have been more thoroughly characterised. To investigate the effect of these MECP2 mutations on MHC class I expression, we transiently transfected the N2A cell line with plasmids expressing well-characterised mutants of both the A and B isoforms of MeCP2 (T158M, R133C, R306C and R308*). The point mutations T158M, R133C and R306C are located in the functional MBD and TRD domains of the protein (Figure 3A). The mutant form that is truncated after the R308 residue corresponds to the form of MeCP2 found in the mouse model of RTT generated by Dr. Zoghbi's group [13]. We performed mutagenesis on vectors expressing either the A or B form of Myc-tagged MeCP2. All the mutated plasmids were sequenced and checked for functional expression and intracellular localisation of the wild-type and mutated MeCP2 proteins by anti-Myc immunofluorescence on transiently transfected N2A cells (Figure 3B). All the mutant forms of Myc-taged MeCP2 were located in intranuclear punctate structures typical of the wild-type protein, which forms foci on heterochromatin [22], [49] (data is shown for the R133C MeCP2A-Myc mutant and the wild-type pMeCP2A-Myc protein only). Subsequently, we evaluated the cell-surface expression level of MHC class I in the transiently transfected N2A cells by flow cytometry using the rat anti-pan-MHC I antibody M1/42, as before. The intracellular MeCP2 level was evaluated based on the intensity of immunostaining for the Myc tag, and was found to be similar to the wild-type for both the A and B forms of the four mutants. The R133C MeCP2A-Myc mutant had the same effect as its wild-type counterpart on the cell-surface level of MHC class I (Figure 3C), whereas neither mutant nor wild type had a significant effect on expression of the transferrin receptor (not shown). Similar effects were found for both A and B isoforms of all four mutants tested (Data for T158M R306C and R308* are not shown). Thus, these mutations responsible for RTT do not abolish the repressive effect of MeCP2 on MHC class I in cells in culture. These results strongly suggest that the repressive function of MeCP2 on the levels of MHC molecules expressed by transiently transfected cells in vitro is unlikely to be directly related to the pathogenesis of Rett syndrome.
###end p 29
###begin title 30
Mutant forms of MeCP2 that cause RTT retain their repressive effect on MHC class I expression.
###end title 30
###begin p 31
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 968 969 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 979 980 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 514 519 <span type="species:ncbi:10090">mouse</span>
###xml 578 583 <span type="species:ncbi:10090">mouse</span>
Panel A: Schematic representation of the MeCP2 protein. Red and orange arrows indicate the positions of the mutations introduced in MeCP2 by site-directed mutagenesis (MBD: methyl-CpG binding domain, TRD: transcription repression domain, WW: group II WW-domain-binding region). Panel B: N2A cells transfected with empty pcDNA3.1 (mock cells), with pcDNA3.1 expressing Myc-tagged MeCP2A (pMeCP2A-myc) or with pcDNA3.1 expressing Myc-tagged MeCP2A with the R133C point mutation (pMeCP2A-R133C-myc) were stained with mouse anti-Myc 9E10 monoclonal antibody, and FITC-labelled anti-mouse IgG antibody. Coverslips were mounted in DAPI-containing ProLong Gold antifade reagent (Molecular Probes) before observation by fluorescence microscopy. Panel C: N2A cells transfected as in panel B were double immunostained for cell surface MHC class I and intracellular Myc-tagged MeCP2, then analysed by flow cytometry. Similar data were obtained for all four mutated forms of MeCP2A and MeCP2B (not shown), and these observations were reproduced in three independent transfection experiments.
###end p 31
###begin title 32
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Expression of MHC class I in cells from MeCP2-knockout mice is no different to that in cells from wild-type mice
###end title 32
###begin p 33
###xml 328 337 325 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird</sup>
###xml 819 827 816 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g004">Figure 4</xref>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 540 543 <span type="species:ncbi:10116">rat</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
Our data from experiments with cells in culture (above) suggest that the genes encoding MHC class I and beta2-microglobulin are controlled by MeCP2; overexpression of normal MeCP2 downregulates their expression. To find out whether this is the case in vivo, we investigated whether neuronal cells from MeCP2 knockout mice (MeCP2tm1.1Bird) contained elevated levels of MHC class I by performing immunohistochemistry on frozen brain sections of MECP2 knockout hemizygous male (-/y) mice and of their wild-type littermates using two different rat monoclonal antibodies directed against mouse MHC class I molecules. The results we obtained suggest that there are slightly higher levels of MHC class I expression in some regions of the brains of MeCP2 knockout mice than in the same regions of the wild-type control brains (Figure 4). Although these differences were not always seen for all brain areas of MECP2 knockout mice compared to their control littermates, when a difference was seen, it was always for higher expression in MECP2 knockout animals.
###end p 33
###begin title 34
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Evaluation of MHC class I expression in adult mouse brain slices.
###end title 34
###begin p 35
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/y</sup>
###xml 150 153 <span type="species:ncbi:10116">rat</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
Serial frozen sections of adult male wild-type and MeCP2-/y littermates were analysed for expression of MHC class I by immunohistochemistry using the rat R1-21.2 monoclonal antibody and EnVision detection technology (Dako). For the negative control, the same staining process was used omitting the primary antibody. Similar results were obtained with the M1/42 monoclonal antibody. Similar results were obtained in independent experiments on brains from three different pairs of mice.
###end p 35
###begin p 36
###xml 516 529 516 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird +/&#8722;</sup>
###xml 854 862 850 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g005">Figure 5</xref>
###xml 1018 1027 1010 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g005">Figure 5A</xref>
###xml 1098 1111 1090 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird &#8722;/y</sup>
###xml 1253 1266 1245 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird &#8722;/+</sup>
###xml 1301 1314 1293 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird &#8722;/y</sup>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 585 590 <span type="species:ncbi:10090">mouse</span>
The immunohistochemistry approach did not allow us to quantify the small variations we observed in MHC class I expression between MeCP2 knockout and wild-type mice or to identify the cell types that expressed MHC class I in the absence of MeCP2 (neurons, astrocytes, oligodendrocytes or endothelial cells). We therefore decided to look at primary cultures of brain cells (called mixed glial cells; MGCs) and fibroblasts from spleen taken from individual 2-day-old mice born from crossing a heterozygous female (MeCP2tm1.1Bird +/-) with a wild-type male. The tail DNA from each newborn mouse used to prepare the cell lines was analysed to establish the genotype of each culture. On the second day of culture, the MGCs were treated with IFN-gamma or not and then analysed two days later for expression of MHC class I on the cell surface by flow cytometry (Figure 5). The fibroblast cultures, which took a few more days to establish, were similarly treated with IFN-gamma after five days and analysed on the seventh day. Figure 5A shows typical examples of histograms obtained with wild-type and MeCP2tm1.1Bird -/y male littermates. Similar data were obtained for all four genotypes: wild-type female (+/+) and male (+/y), heterozygous mutant female (MeCP2tm1.1Bird -/+) and hemizygous mutant male (MeCP2tm1.1Bird -/y).
###end p 36
###begin title 37
Deletion of MECP2 does not affect basal or IFN-gamma -induced MHC class I expression in primary cultures of mixed glial cells.
###end title 37
###begin p 38
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/y</sup>
###xml 784 787 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/y</sup>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 1160 1164 <span type="species:ncbi:10090">mice</span>
Mixed glial cell cultures established from two-day old wild-type, MeCP2+/- and MeCP2-/y mice (10, 6 and 8 animals per group, respectively) were treated or not with IFN-gamma on the second day of culture and analysed two days later by flow cytometry for MHC class I expression. Neurons were identified by their intracellular staining with an anti-beta-III-tubulin antibody (inset). Large cells, containing mainly astrocytes, were analysed separately by an appropriate forward/side scatter gate. Primary spleen fibroblasts from the same mice were also subjected or not to IFN-gamma treatment and stained for their MHC class I expression. Panel A: Representative histograms showing cell surface staining (x axis) against cell number (y axis), obtained with cells from wild-type and MeCP2-/y male littermates. White-filled curves represent background staining, gray-filled curves represent MHC I-specific staining. Panel B: MHC class I fold-induction in response to IFN-gamma was calculated as the ratio of MFI of treated cells (induced MHC I level) on MFI of untreated cells (basal MHC I level). Grey-filled squares show MHC class I fold-induction for individual mice and for each cell type. White-filled squares represent the group's mean of fold-inductions (+/-SD).
###end p 38
###begin p 39
###xml 52 56 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 117 126 114 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g005">Figure 5A</xref>
###xml 426 430 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-McLaren1">[50]</xref>
###xml 453 462 446 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g005">Figure 5A</xref>
Neurons, which we identified by their expression of betaIII-tubulin and their smaller size (see population R2, inset Figure 5A), had no detectable MHC class I (grey-filled curves) when compared to background (white-filled curves), and treatment with IFN-gamma induced a small amount of MHC class I in cells from both the wild-type and knockout animals. Astrocytes, which comprise the majority of the population of large cells [50] (population R1, inset Figure 5A), spontaneously expressed more MHC class I, which was highly induced by IFN-gamma but no significant differences were seen between the two genotypes. Although the populations in the cultures of spleen-derived fibroblasts were much more heterogeneous, similar levels of MHC class I were found in the cells from the wild-type and knockout animals. These measurements were performed on cell cultures derived from 24 newborn animals from nine independent litters, with very similar results.
###end p 39
###begin p 40
###xml 169 178 165 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001354-g005">Figure 5B</xref>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
To compare data obtained in independent experiments, we plotted the fold-induction of MHC class I expression after treatment with IFN-gamma compared to untreated cells. Figure 5B displays the fold-induction of MHC class I by IFN-gamma in each cell culture derived from an individual mouse as well as the mean for cell cultures of each genotype. No significant differences were found between wild-type and MeCP2-knockout cells. The deficiency in MeCP2 thus affects neither the basal nor the inducible MHC class I expression level in primary MGC cultures.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 32 36 32 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Corriveau1">[40]</xref>
###xml 38 42 38 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Huh1">[41]</xref>
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Goddard1">[51]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Corriveau1">[40]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Huh1">[41]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Goddard1">[51]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Jung1">[52]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Mullaney1">[54]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Shahbazian3">[55]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kishi1">[56]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-LaSalle1">[57]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nan2">[21]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Tykocinski1">[39]</xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Reports by Shatz and colleagues [40], [41], [51] have demonstrated clearly that tight regulation of MHC class I genes in the CNS contributes to the establishment and maintenance of neuronal connections during development, as well as to plastic remodelling in the hippocampus and to neuronal signalling in specific areas of the brain [40], [41], [51]. We reasoned that the transcriptional repressor MeCP2 might be involved in regulating MHC class I expression in the CNS for three main reasons. Firstly, expression of MeCP2 is strictly regulated during development [52]-[54] and specifically in various cell types [55] and is highest in mature neurons [56], [57], which do not express MHC class I. Secondly, MeCP2 binds to methylated cytidine residues on CpG dinucleotides [21] and the genes for MHC class I are particularly rich in C/G residues [39]. Thirdly, mutations in the MECP2 gene are responsible for the neurodevelopmental disorder RTT. We hypothesised that MeCP2 represses expression of MHC class I and that mutations responsible for RTT might cause the loss of this activity.
###end p 42
###begin p 43
###xml 237 241 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 465 469 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
In support of the first part of this hypothesis, we showed clearly that overexpression of either of the two isoforms of MeCP2 by transient transfection of neuronal and fibroblastic cell lines results in reduced levels of MHC class I and beta2-microglobulin at the cell surface. Furthermore, overexpression of MeCP2 blocked induction of MHC class I in these cells in response to IFN-gamma. We could not determine whether this decreased expression of MHC class I and beta2-microglobulin in response to MeCP2 overexpression was due to reduced transcription, translation or transport to the cell surface because the cells were transiently transfected; only cells that expressed high levels of MeCP2 showed reduced levels of MHC class I on their surface, so we could not quantify the levels of mRNA by RT-PCR or northern blot.
###end p 43
###begin p 44
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 122 126 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
The fact that we observed very similar extents of repression of all three MHC class I forms (Kk, Ld and Dd) as well as of beta2-microglobulin suggests that MeCP2 probably does not act directly on the promoters of the various loci encoding MHC class I, which are not identical. These considerations lead us to think that the effect of MeCP2 may be a more 'global', indirect mechanism than transcriptional repression by binding to methyl cytosine in the promoters.
###end p 44
###begin p 45
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Ritz1">[58]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-York1">[59]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Georgel1">[30]</xref>
The global decrease in cell surface MHC class I in MeCP2-expressing cells might be due to an effect on chromatin architecture encompassing the whole MHC region, which includes, in addition to the MHC class I loci, other genes involved in the assembly and transport of MHC molecules [58], [59] that might contribute to a global effect. If MeCP2 condenses the chromatin in the MHC region, this might block access of transcription factors and regulatory factors to the genes, as suggested by the work of Georgel and colleagues [30]. Such chromatin condensation would also explain the failure of IFN-gamma to induce MHC class I in cells overexpressing MeCP2 if it prevented IFN regulatory factors from binding to their response element.
###end p 45
###begin p 46
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Georgel1">[30]</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina1">[60]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Horike1">[31]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Georgel1">[30]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina2">[61]</xref>
Our findings that the MeCP2 forms mutated either in the MBD or TRD domains conserve their repressive effect on MHC class I expression strengthen this interpretation that MeCP2 has an indirect effect on transcription through its effect on chromatin architecture. These mutations affect only transcriptional repression by MeCP2, preventing it from binding to methylated DNA and from recruiting repressor partners, but the other functions of the protein are not affected, particularly its capacity to silence gene expression by driving chromatin condensation [30], [60] and stabilising large silencing chromatin loops [31]. The ability of MeCP2 to condense chromatin by methylation-independent DNA binding relies on regions within the N-terminal 294 residues, distinct from the MBD [30], [61].
###end p 46
###begin p 47
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina1">[60]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina1">[60]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina2">[61]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Georgel1">[30]</xref>
###xml 1367 1371 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina1">[60]</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Nikitina2">[61]</xref>
MeCP2 induces chromatin condensation in three successive steps: first, it binds to the linker DNA between nucleosomes; second, it brings the nucleosomes together in a 'stem conformation' through DNA-protein interactions, and third, it binds to the nucleosomes themselves to produce full chromatin compaction [60]. Whereas the C-terminal region of MeCP2 is dispensable for the two first steps, it is apparently required for maximal compaction of the chromatin since the R294X mutation abolishes bridging between nucleosomes [60], [61]. By contrast, the R133C mutation, which abolishes the selective recognition of methylated DNA, retains the chromatin compaction properties of the wild-type protein [30]. The two other point mutations we tested in this study, T158M and R306C, like R133C, may retain their compaction properties and thus their repressive effect on MHC genes. Our findings with the truncated form R308*, which also retains the same repressive effect on MHC class I expression as the wild-type protein, indicate that the repression of MHC genes by MeCP2 does not involve the C-terminal portion of the protein. The effects of MeCP2 on MHC expression therefore probably does not involve the third step of MeCP2-induced chromatin condensation (above) but may involve a conformational change in the 'stem organization' of the chromatin around the MHC region [60], [61].
###end p 47
###begin p 48
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 143 152 143 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird</sup>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Guy1">[11]</xref>
###xml 822 826 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1049 1054 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
If MeCP2 represses MHC class I expression, we expected to see elevated levels of MHC class I in the brains of MECP2 knockout mice (strain MeCP2tm1.1Bird) when compared to mice with fully functional MECP2[11]. When we stained brain slices immunohistochemically with two different antibodies, we saw a small but reproducible increase in MHC class I expression in the brains of three knockout male mice when compared to those of their wild-type littermates, but these results were purely qualitative, and it was not possible to quantify these differences by immunohistochemistry. We decided, therefore, to produce primary cultures of MGCs from knockout mice in order to quantify MHC class I expression by flow cytometry. This approach also allowed us to distinguish a neuronal population, comprised of small cells expressing betaIII-tubulin, and a population of large cells comprised mostly of astrocytes. This quantitative analysis detected no difference between MHC class I levels on the surface of cells derived from animals carrying an inactivated MECP2 gene and those from their wild-type littermates whether for the basal level of MHC class I expression or for the level induced by IFN-gamma. This was true for the neuronal population and the astrocyte population, as well as for primary cultures of spleen fibroblasts.
###end p 48
###begin p 49
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Jung1">[52]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Cohen1">[53]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Shahbazian3">[55]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-LaSalle1">[57]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Balmer1">[62]</xref>
###xml 786 790 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1218 1223 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
We conclude from these studies that there may be a small quantitative increase in MHC class I in the brains of MECP2 knockout mice when compared to the wild type but this increase is not seen in isolated primary MGCs containing mostly neurons and astrocytes. The possibility remains that the levels of MeCP2 in these primary cell cultures were insufficient to see a difference. Indeed, our experiments with N2A cells showed that relatively high levels of MeCP2 are necessary to observe its repressive effect on MHC class I expression. Several studies have shown a direct correlation between age and MeCP2 expression, with maximal levels of expression in post-mitotic mature and differentiated neurons [52], [53], [55]-[57], [62]. Although the neuronal populations in our MGCs expressed betaIII-tubulin, a marker of neuronal differentiation, they were very probably far from being fully mature. In support of this, we were unable to detect MeCP2 expression in neonatal MGCs by flow cytometry (not shown). The neurons that we analysed in neonate MGC might therefore have been too immature to demonstrate a defect in MHC regulation due to MeCP2 deficiency. It was, however, not feasible to obtain brain tissue from adult MECP2 knockout animals for these studies because the mice die at around eight weeks old.
###end p 49
###begin p 50
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Colantuoni1">[63]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Traynor1">[65]</xref>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Colantuoni1">[63]</xref>
###xml 116 121 <span type="species:ncbi:9606">girls</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 412 419 <span type="species:ncbi:9606">patient</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
Three groups have performed transcriptome analyses on microarrays of cDNA prepared from post-mortem brain tissue of girls with RTT and from the brains of MECP2 knockout mice [63]-[65]. At least one of these studies supports the idea that MeCP2 may influence MHC expression in the CNS: Colantuoni et al.[63] found a 5.8-fold increase in expression of the mRNA for the MHC class I molecule HLA-A in a RTT syndrome patient relative to matched controls. This small increase in MHC class I expression in the absence of MeCP2 is consistent with our hypothesis and further suggests that such subtle disregulation might be detectable only in older mice than those we used in our study.
###end p 50
###begin p 51
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Lam1">[66]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Beyer1">[67]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Watson1">[68]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Couvert1">[69]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Orrico1">[70]</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-ClaytonSmith1">[71]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Villard1">[72]</xref>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Collins1">[73]</xref>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Ariani1">[74]</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Lugtenberg1">[77]</xref>
###xml 1469 1473 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Goddard1">[51]</xref>
###xml 1629 1633 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1656 1660 1653 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Huh1">[41]</xref>
###xml 983 988 <span type="species:ncbi:10090">mouse</span>
###xml 1015 1020 <span type="species:ncbi:9606">human</span>
###xml 1651 1655 <span type="species:ncbi:10090">mice</span>
We found that the forms of MeCP2 carrying RTT-causing mutations retained their repressive function on MHC expression in transiently transfected cells. Although this observation does not go against our findings that MeCP2 can down-regulate MHC expression in cells where it is expressed at high levels, these results lead us to conclude that repression of MHC class I expression by MeCP2 is very probably not directly relevant to the pathogenesis of RTT. Mutations in the MECP2 gene are also suspected to be at the origin of a large panel of other neurological diseases such as autism [66], [67], Angelman syndrome [68], X-linked mental retardation [69], [70], and severe neonatal encephalopathy [71], [72]. It may therefore be that those types of mutations responsible for other diseases could be related to the MHC-regulating activity of MeCP2. Additionally, the majority of MECP2 mutations in RTT are loss-of-function mutations, but overexpression of MECP2 by gene duplication in a mouse model [73], as well as in human clinical cases [74]-[77], also causes mental retardation and progressive neurological diseases. Since high levels of MeCP2 can repress cell surface expression of MHC class I, at least in neuronal cell lines, MeCP2 overexpression might result in an overrepression of MHC gene expression in the CNS, which may contribute to certain pathologies by preventing MHC molecules from fulfilling their roles during CNS development and in synaptic plasticity [51]. Inappropriate temporal and spatial repression of MHC genes by overexpressed MeCP2 might induce defects in neuronal functions similar to those observed in beta2m/TAP1 deficient mice [41]. Further experiments will be required to explore this eventuality.
###end p 51
###begin p 52
This leaves us with the important conclusion that high levels of MeCP2, like those found in mature neurons, repress expression of MHC class I molecules and this may be an important physiological factor contributing to the repression of MHC class I in the CNS.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 54
###begin p 55
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEPC2</italic>
###xml 30 39 30 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1.1Bird</sup>
###xml 64 96 64 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Institute for Stem Cell Research</italic>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Miralves1">[78]</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
The MEPC2 knockout mice (MeCP2tm1.1Bird) were obtained from the Institute for Stem Cell Research, Edinburgh, UK. These mice have a RTT-like progressive neurodevelopmental disease very similar to that seen in patients; the males (-/y) suffer from a much more severe form of the disease than the heterozygous (+/-) females, and are sterile. MeCP2+/- female mice were mated with C57BL/6 male mice purchased from the Centre de Recherche et d'Elevage, Janvier, France. The litters obtained were genotyped initially as recommended by the Jackson Laboratory, and later with an optimised set of primers [78]. All experiments involving animals were performed in compliance with the relevant laws and institutional guidelines.
###end p 55
###begin title 56
Cell lines
###end title 56
###begin p 57
###xml 71 75 <span type="species:ncbi:9913">calf</span>
The N2A and NIH 3T3 cell lines were maintained in DMEM with 10% foetal calf serum (FCS) and antibiotics. For the origin and description of these cell lines see ATCC.
###end p 57
###begin title 58
Antibodies
###end title 58
###begin p 59
###xml 31 37 <span type="species:ncbi:9986">rabbit</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 127 133 <span type="species:ncbi:9986">rabbit</span>
Polyclonal primary antibodies: rabbit anti-MeCP2 polyclonal IgG (Upstate), mouse anti- C terminal peptide of MeCP2 (Sigma) and rabbit anti-beta III-tubulin polyclonal IgG (Abcam).
###end p 59
###begin p 60
###xml 107 109 107 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 142 144 142 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 173 175 173 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sup>
###xml 218 220 218 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</sup>
###xml 262 264 262 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 296 298 296 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 326 328 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 381 383 381 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 434 436 434 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 92 95 <span type="species:ncbi:10116">rat</span>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 395 398 <span type="species:ncbi:10116">rat</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
Hybridoma supernatants from clones (obtained from ATCC): 9E10 (mouse anti-myc IgG1), M1/42 (rat anti-H2 IgG2a), R1-21.2 (rat anti-mouse H2 IgG2b), HB25 (mouse anti-H2 Kk IgG2a), 28.14.8 (mouse anti-H2 Db, Ld and Dq IgG2a), 30.5.7 (mouse anti-H2 Ld, Dq and Lq IgG2a), 34.4.20 (mouse anti-H2 Dd IgG2a), Y-3 (mouse anti-H2 Kb IgG2b), S19.8 (mouse anti-beta 2 microglobulin b and c IgG2b), R17.217 (rat anti-mouse transferrin receptor IgG2a).
###end p 60
###begin p 61
###xml 39 43 <span type="species:ncbi:9925">goat</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 79 83 <span type="species:ncbi:9925">goat</span>
###xml 89 95 <span type="species:ncbi:9986">rabbit</span>
###xml 153 157 <span type="species:ncbi:9925">goat</span>
###xml 163 166 <span type="species:ncbi:10116">rat</span>
###xml 232 236 <span type="species:ncbi:9925">goat</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
Secondary fluorescent antibodies: FITC goat anti-mouse IgG (Dako), fluorescein goat anti-rabbit IgG (H+L) (Molecular Probes, Invitrogen), AlexaFluor 647 goat anti-rat IgG (H+L) (Molecular Probes, Invitrogen), AlexaFluor 647 and 680 goat anti-mouse IgG (H+L) (Molecular Probes, Invitrogen).
###end p 61
###begin title 62
Plasmids
###end title 62
###begin p 63
###xml 67 68 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 95 99 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kriaucionis1">[18]</xref>
###xml 101 105 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Hendrich1">[79]</xref>
###xml 160 161 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 171 172 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 172 176 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Mnatzakanian1">[19]</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 242 250 <span type="species:ncbi:9606">Children</span>
pCMX vectors expressing mouse MeCP2alpha, MeCP2beta and human MeCP2A were described previously [18], [79]. pcDNA3.1(A) vectors expressing Myc-tagged human MeCP2A and MeCP2B[19] were provided by Dr. Berge A. Minassian of the Hospital for Sick Children, Toronto, Ontario, Canada.
###end p 63
###begin title 64
Mutagenesis
###end title 64
###begin p 65
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001354-Kirsch1">[80]</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Site-directed mutagenesis of pcDNA3.1(A) vectors driving expression of Myc-tagged human MeCP2A and MeCP2B was carried out as described previously [80]. Briefly, during a first PCR reaction typically [9x (95degreesC for 30 s, 55degreesC for 1 min, 68degreesC for 1 min)] using high-fidelity Taq polymerase (Invitrogen), a DNA template was generated between a forward T7 oligonucleotide (5'-GTAATACGACTCACTATAG-3') annealing to pcDNA3.1 (A) upstream of the multiple cloning site and a reverse oligonucleotide annealing to the MeCP2 sequence and carrying the chosen mutations:
###end p 65
###begin p 66
R133C: 5'-aatcaactccactttactgcagaaggcttttccctg-3'
###end p 66
###begin p 67
T158M: 5'-ccctctcccagttaccatgaagtcaaaatcatt-3'
###end p 67
###begin p 68
R306C: 5'-gatgctgaccgtctcacgcgtcttgcacttcttgatggggag-3'
###end p 68
###begin p 69
###xml 507 510 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dpn</italic>
These primers were designed to produce or remove a restriction enzyme site allowing simple screening of the recovered plasmids (gain of an PstI site for R133C; gain of an NlaIII site for T158M, and loss of an SmaI site for R306C). During a second PCR reaction [9x (95degreesC for 30 s, 68degreesC for 6 min)], the newly amplified DNA fragments served as megaprimers to complete the synthesis of the remainder of the plasmids. The extension time of the last cycle was 16 min, followed by digestion with 10 U DpnI at 37degreesC for 1 hr to destroy the original methylated plasmids. The mutated plasmids were recovered by transforming competent DH5alpha bacteria and they were screened by restriction digest. The sequence of the inserts corresponding to the MeCP2 open reading frame was then checked by direct sequencing.
###end p 69
###begin p 70
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 312 313 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
To generate pcDNA3.1 plasmids expressing the R308* truncated forms of Myc-tagged MeCP2A and MeCP2B, a PCR reaction [12x (94degreesC, 45 s; 50degreesC, 45 s; 68degreesC, 2 min 30 s), 12x (94degreesC, 45 s; 68degreesC, 2 min 30 s)] using high-fidelity Taq polymerase (Invitrogen), was carried out on pcDNA3.1-MeCP2A using the following oligonucleotides:
###end p 70
###begin p 71
Forward T7 primer: 5'-GTAATACGACTCACTATAG-3'
###end p 71
###begin p 72
Reverse primer: 5'-gcgtctagagagggtggacaccagca-3'
###end p 72
###begin p 73
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 381 386 <span type="species:ncbi:9606">human</span>
The reverse common primer, annealing in the MECP2 sequence, was designed to include an XbaI restriction site immediately following residue 308 of MeCP2, which is also located upstream of the sequence encoding the Myc tag in the original pcDNA3.1 Myc plasmid. The amplified MeCP2(1-308) sequence was digested with XcmI and XbaI and ligated, using T4 DNA ligase (NEB), into pcDNA3.1 human MeCP2A or B myc-tagged plasmids digested with the same enzymes. The plasmids expressing truncated Myc-tagged MeCP2A and B forms were recovered by transforming competent DH5alpha bacteria and they were screened by restriction digest. The sequence of the inserts corresponding to the MeCP2(R308*) open reading frame was then checked by direct sequencing.
###end p 73
###begin title 74
Transfection
###end title 74
###begin p 75
###xml 232 233 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 352 353 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 363 364 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Transfections were carried out using FuGENE 6 (Roche Applied Bioscience), following the manufacturer's instructions (using 2 microg of plasmid and 6 microl of transfection reagent). Briefly, N2A or NIH 3T3 cells were plated in 25 cm2 flasks at least 12 hrs before transfection. Stable N2A transfectants expressing Myc-tagged wild-type and mutated MeCP2A and MeCP2B were selected by adding 0.5 mg/ml of G418 three days after transfection, and the populations obtained were subsequently maintained in this selecting medium.
###end p 75
###begin title 76
Quantitative Western Blot
###end title 76
###begin p 77
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 419 424 <span type="species:ncbi:10090">mouse</span>
###xml 499 504 <span type="species:ncbi:10090">mouse</span>
Whole cellular extracts from adult mouse brain, and from transiently and stably transfected N2A cells were prepared, and blotted on nitrocellulose after separation by 4-12% SDS-PAGE (50 microg of cellular extract per sample). Levels of MeCP2 were then measured on an Odyssey infrared scanner (Li-Cor) after staining with a mouse anti-MeCP2 polyclonal antibody (C terminal portion, Sigma), followed by an Alexa 680 anti-mouse secondary antibody. Normalisation between samples was carried out using a mouse monoclonal against GAPDH (ab9484, abcam) and the same secondary reagent on the lower part of the same blot.
###end p 77
###begin title 78
Cells staining and cytometry
###end title 78
###begin p 79
###xml 65 69 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 626 631 623 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-</italic>
For immunochemical staining of the cell surface for MHC class I, beta-2-microglobulin or transferrin receptor, cells were harvested by trypsinisation and washed once with medium to obtain a single-cell suspension. The resuspended cells were then incubated on ice with a saturating concentration of the appropriate hybridoma supernatant. Thirty minutes later, cells were washed three times in phosphate-buffered saline (PBS) containing 2% FCS, then incubated for thirty minutes on ice with the suitable secondary reagent and washed three times before fixation in PBS containing 1% paraformaldehyde. When intracellular MeCP2 or beta-III-tubulin was also analysed, further staining steps were performed as described above, but adding 0.3% saponin in all buffers. Labelled cells were analysed using a FACScalibur cytometer and CellQuest software (BD Biosciences). Dead cells were excluded using appropriate forward/side scatter gates.
###end p 79
###begin title 80
Immunohistochemistry of brain slices
###end title 80
###begin p 81
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/y</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 410 416 <span type="species:ncbi:9913">bovine</span>
###xml 643 646 <span type="species:ncbi:10116">rat</span>
###xml 746 752 <span type="species:ncbi:9986">rabbit</span>
###xml 758 761 <span type="species:ncbi:10116">rat</span>
###xml 903 907 <span type="species:ncbi:9925">goat</span>
###xml 913 919 <span type="species:ncbi:9986">rabbit</span>
Brains from adult MeCP2-/y and wild-type mice were embedded in Tissue-Tek OCT compound (Sakura) and frozen in dry ice-cold isopentane. Serial coronal sections of 10 microm were cut with a cryostat at -20degreesC, placed on Super Frost Plus slides (Menzel-Glaser), air dried overnight at room temperature and fixed in acetone and air dried rapidly. The tissue sections were then rehydrated in PBS containing 3% bovine serum albumin (BSA) and endogenous peroxidase activity was quenched by incubating with peroxydase block reagent (Dako). Following washes in PBS containing 1% BSA, the specimens were incubated with saturating concentrations of rat hybridoma supernatant for 1 hr and then rinsed in PBS containing 1% BSA before incubation with the rabbit anti-rat Ig antibody Z0494 (Dako). The sections were then treated with EnVision as instructed by the manufacturer (Dako) using a labelled polymer-HRP goat anti-rabbit Ig. Finally, slides were mounted in Mowiol. Observation and image acquisitions were carried out on a Leica RM-IRB microscope using the 10x objective. Pictures were taken with a COHU CCD camera.
###end p 81
###begin title 82
Immunofluorescence staining
###end title 82
###begin p 83
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
N2A cells growing on coverslips were transfected with empty pcDNA3.1(+), with pcDNA3.1 expressing Myc-tagged wild-type MeCP2A or B, or pcDNA3.1 expressing Myc-tagged mutated MeCP2A or B containing the T158M, R133C, R306C or R308* mutations. Cells were fixed with acetone and incubated with mouse anti-Myc monoclonal antibody (9E10) followed by FITC-labelled anti-mouse IgG antibody for 30 min at room temperature. After the final wash, the coverslips were mounted in DAPI-containing ProLong Gold antifading reagent (Molecular Probes). Observation and image acquisition were carried out on a Leica RM-IRB microscope using 40x or 20x objectives. Pictures were taken with a COHU CCD camera and acquired as TIFF stacks of images with Q-Fluoro software, after integration of the signal for 1 sec for in the case of FITC labelling (no integration of the signal was necessary for DAPI labelling).
###end p 83
###begin title 84
Primary cultures
###end title 84
###begin p 85
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 506 507 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Brains removed from two-day old mice were cut in small pieces in ice-cold PBS containing glucose, then centrifuged at 80 g for 5 min at 4degreesC and digested with trypsin (Gibco) for 40 min at 37degreesC. The trypsin was blocked by adding DMEM supplemented with 10% FCS for 5 min at room temperature. The digested brain material was then washed twice with DMEM containing 10% FCS and once in neurobasal medium (Gibco) supplemented with B27 and 2% FCS, and recovered between washes by centrifugation at 80 g for 5 min at 4degreesC. During the final wash, mechanical dissociation of the cells into a single-cell suspension was achieved by pipetting up and down several times. Brain cell suspensions were plated on six-well plates coated at least 12 hrs before with poly-D-ornithine (SIGMA) and maintained in neurobasal medium containing B27 and 2% FCS.
###end p 85
###begin p 86
For cultures of splenic fibroblasts, spleens were cut into small pieces in PBS/glucose, digested in trypsin and washed, as above, and finally plated on six-well plates and maintained in RPMI containing 10% FCS.
###end p 86
###begin p 87
We would like to thank Dr. Brian Hendrich for his gift of reagents and helpful discussions, Drs Berge Minassian, and Adrian Bird for their gifts of plasmids, Denis Hudrisier and Jean Charles Guery for helpful suggestions and discussions, and Carol Featherstone for her help with the manuscript.
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
###end article-title 89
###begin article-title 90
Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28.
###end article-title 90
###begin article-title 91
MECP2 mutations account for most cases of typical forms of Rett syndrome.
###end article-title 91
###begin article-title 92
Rett syndrome. Current status and new vistas.
###end article-title 92
###begin article-title 93
###xml 87 92 <span type="species:ncbi:9606">girls</span>
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
###end article-title 93
###begin article-title 94
Rett syndrome: a prototypical neurodevelopmental disorder.
###end article-title 94
###begin article-title 95
###xml 21 27 <span type="species:ncbi:9606">humans</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
MeCP2 dysfunction in humans and mice.
###end article-title 95
###begin article-title 96
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Genetic and physical mapping of a gene encoding a methyl CpG binding protein, Mecp2, to the mouse X chromosome.
###end article-title 96
###begin article-title 97
###xml 67 72 <span type="species:ncbi:9606">human</span>
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2.
###end article-title 97
###begin article-title 98
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
###end article-title 98
###begin article-title 99
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
###end article-title 99
###begin article-title 100
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.
###end article-title 100
###begin article-title 101
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.
###end article-title 101
###begin article-title 102
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
###end article-title 102
###begin article-title 103
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
###end article-title 103
###begin article-title 104
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
###end article-title 104
###begin article-title 105
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Reversal of neurological defects in a mouse model of Rett syndrome.
###end article-title 105
###begin article-title 106
The major form of MeCP2 has a novel N-terminus generated by alternative splicing.
###end article-title 106
###begin article-title 107
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome.
###end article-title 107
###begin article-title 108
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
###end article-title 108
###begin article-title 109
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
###end article-title 109
###begin article-title 110
DNA methylation specifies chromosomal localization of MeCP2.
###end article-title 110
###begin article-title 111
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
###end article-title 111
###begin article-title 112
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
###end article-title 112
###begin article-title 113
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
###end article-title 113
###begin article-title 114
MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.
###end article-title 114
###begin article-title 115
The Ski protein family is required for MeCP2-mediated transcriptional repression.
###end article-title 115
###begin article-title 116
Components of the DNA methylation system of chromatin control are RNA-binding proteins.
###end article-title 116
###begin article-title 117
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
###end article-title 117
###begin article-title 118
###xml 24 29 <span type="species:ncbi:9606">human</span>
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.
###end article-title 118
###begin article-title 119
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
###end article-title 119
###begin article-title 120
Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
###end article-title 120
###begin article-title 121
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
###end article-title 121
###begin article-title 122
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.
###end article-title 122
###begin article-title 123
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
###end article-title 123
###begin article-title 124
###xml 40 44 <span type="species:ncbi:10090">mice</span>
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
###end article-title 124
###begin article-title 125
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
###end article-title 125
###begin article-title 126
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome.
###end article-title 126
###begin article-title 127
CG dinucleotide clusters in MHC genes and in 5' demethylated genes.
###end article-title 127
###begin article-title 128
Regulation of class I MHC gene expression in the developing and mature CNS by neural activity.
###end article-title 128
###begin article-title 129
Functional requirement for class I MHC in CNS development and plasticity.
###end article-title 129
###begin article-title 130
Induction of MHC class I genes in neurons.
###end article-title 130
###begin article-title 131
Expression of T cell receptor beta locus in central nervous system neurons.
###end article-title 131
###begin article-title 132
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Combinatorial coexpression of neural and immune multigene families in mouse vomeronasal sensory neurons.
###end article-title 132
###begin article-title 133
###xml 25 31 <span type="species:ncbi:10090">murine</span>
Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules.
###end article-title 133
###begin article-title 134
MHC class I peptides as chemosensory signals in the vomeronasal organ.
###end article-title 134
###begin article-title 135
Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.
###end article-title 135
###begin article-title 136
Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
###end article-title 136
###begin article-title 137
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.
###end article-title 137
###begin article-title 138
Analysis of neural stem cells by flow cytometry: cellular differentiation modifies patterns of MHC expression.
###end article-title 138
###begin article-title 139
Regulation of CNS synapses by neuronal MHC class I.
###end article-title 139
###begin article-title 140
###xml 109 112 <span type="species:ncbi:10116">rat</span>
The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
###end article-title 140
###begin article-title 141
Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis.
###end article-title 141
###begin article-title 142
Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain.
###end article-title 142
###begin article-title 143
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation.
###end article-title 143
###begin article-title 144
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
###end article-title 144
###begin article-title 145
Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
###end article-title 145
###begin article-title 146
The transporter associated with antigen processing (TAP): structural integrity, expression, function, and its clinical relevance.
###end article-title 146
###begin article-title 147
Antigen processing and presentation by the class I major histocompatibility complex.
###end article-title 147
###begin article-title 148
Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
###end article-title 148
###begin article-title 149
MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome.
###end article-title 149
###begin article-title 150
###xml 78 83 <span type="species:ncbi:9606">human</span>
Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation.
###end article-title 150
###begin article-title 151
###xml 94 101 <span type="species:ncbi:9606">patient</span>
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification.
###end article-title 151
###begin article-title 152
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.
###end article-title 152
###begin article-title 153
Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations.
###end article-title 153
###begin article-title 154
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome.
###end article-title 154
###begin article-title 155
Mutation analysis of the coding sequence of the MECP2 gene in infantile autism.
###end article-title 155
###begin article-title 156
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein.
###end article-title 156
###begin article-title 157
MECP2 is highly mutated in X-linked mental retardation.
###end article-title 157
###begin article-title 158
###xml 23 31 <span type="species:ncbi:9606">patients</span>
MECP2 mutation in male patients with non-specific X-linked mental retardation.
###end article-title 158
###begin article-title 159
Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.
###end article-title 159
###begin article-title 160
###xml 13 17 <span type="species:ncbi:9606">boys</span>
Two affected boys in a Rett syndrome family: clinical and molecular findings.
###end article-title 160
###begin article-title 161
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.
###end article-title 161
###begin article-title 162
Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication.
###end article-title 162
###begin article-title 163
###xml 86 89 <span type="species:ncbi:9606">boy</span>
Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome.
###end article-title 163
###begin article-title 164
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.
###end article-title 164
###begin article-title 165
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH.
###end article-title 165
###begin article-title 166
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Design of an improved set of oligonucleotide primers for genotyping MeCP2tm1.1Bird KO mice by PCR.
###end article-title 166
###begin article-title 167
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
###end article-title 167
###begin article-title 168
An improved PCR-mutagenesis strategy for two-site mutagenesis or sequence swapping between related genes.
###end article-title 168
###begin p 169
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 169
###begin p 170
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded mostly by Association Francaise du Syndrome de Rett (AFSR), as well as core funds from CNRS, salaries were from MRT and FRM for JM, ITAV for EM and INSERM for EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 170

